Frederique Penault-Llorca explains that gene fusions are rare but present in a high number of cancers and several of them are already targetable. From an array of gene fusions, she details on NTRK family which requires a specific approach regarding detection because of an agnostic biomarker’s nature. She details about techniques for detection of alterations and the recommendations for testing algorithm to apply.

Produced by ESMO, www.oncologypro.esmo.org
This video was supported with an educational grant from Bayer. The selection of study results covered in this track is exclusively under the responsibility of ESMO and the speakers selected by ESMO.

свернуть